You don't want to miss this! To permanently access these supporting documents, fill out the short form below. At MaxCyte, we share your passion for the discovery, development, and manufacturing of ...

To permanently access these supporting documents, fill out the short form below. At MaxCyte, we share your passion for the discovery, development, and manufacturing of next generation therapies, ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell and gene therapies. Their core ExPERT ATx, sTX, GTx, and VLx tools use ...

MaxCyte’s ExPERT™ instrument portfolio is the next ... The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related ...

The company, known for its ExPERT™ platform and ... of cell-based therapies. MaxCyte's suite of products includes instruments such as the ATx™, STx™, GTx™, and VLx™, as well as ...

MaxCyte’s ExPERT™ instrument portfolio is the next ... The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related ...

MaxCyte, Inc. (NASDAQ ... a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well ...

Investment analysts at William Blair issued their Q1 2026 earnings estimates for MaxCyte in a report released on Wednesday, March 12th. William Blair analyst M. Larew expects that the company will ...

Fourth Quarter and Full Year Highlights Total revenue of $8.7 million in the fourth quarter of 2024, TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to ...

Under the agreement, TG Therapeutics will gain non-exclusive rights to use MaxCyte's Flow Electroporation technology and ExPERT platform to support the development and commercialization of azer ...

MaxCyte, Inc. engages in the development and ... Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in ...